Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bilirubin-protein interactions monitored by difference spectroscopy.

K O Ash, M Holmer, C S Johnson

    Clinical Chemistry
    |September 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genetic risk in endolysosomal network genes correlates with endolysosomal dysfunction across neural cell types in Alzheimer's disease.

    bioRxiv : the preprint server for biology·2025
    Same author

    Effects of external influences on synthetic cannabinoid trends in New Zealand, 2014 to 2020.

    Forensic science international·2020
    Same author

    Festival testing: A survey of suspected drugs seized from New Zealand music festivals, December 2018 to March 2019.

    Forensic science international·2020
    Same author

    The phenomenon of para-Fluorophenylpiperazine (pFPP) in combination with the synthetic cannabinoid AMB-FUBINACA in seized plant material in New Zealand.

    Forensic science international·2020
    Same author

    The identification and quantification of synthetic cannabinoids seized in New Zealand in 2017.

    Forensic science international·2019
    Same author

    Effect of a Chromosome Segment Marked by the Ph<sub>p</sub> Gene for Resistance to Phytophthora nicotianae on Reproduction of Tobacco Cyst Nematodes.

    Plant disease·2019
    Same journal

    From Pooled Cohorts to PREVENT: A Perspective for Clinical Laboratorians.

    Clinical chemistry·2026
    Same journal

    Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

    Clinical chemistry·2026
    Same journal

    Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

    Clinical chemistry·2026
    Same journal

    Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

    Clinical chemistry·2026
    Same journal

    TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

    Clinical chemistry·2026
    Same journal

    Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

    Clinical chemistry·2026
    See all related articles

    Difference spectroscopy quantifies bilirubin-protein interactions. This rapid assay assesses neonatal serum

    Area of Science:

    • Biochemistry
    • Spectroscopy
    • Neonatal Medicine

    Background:

    • Bilirubin-protein interactions are crucial for understanding bilirubin metabolism and transport.
    • Assessing the binding capacity of serum for bilirubin is vital for managing hyperbilirubinemia in neonates.
    • Kernicterus, a severe form of neonatal jaundice, is linked to unbound bilirubin.

    Purpose of the Study:

    • To develop a rapid and sensitive assay for measuring residual bilirubin binding capacity in serum.
    • To utilize difference spectroscopy for monitoring bilirubin-protein interactions.
    • To establish a method for assessing the risk of kernicterus in neonates.

    Main Methods:

    • Employing difference spectroscopy to monitor changes in spectral absorbance at 482 nm.

    Related Experiment Videos

  • Titrating serum with bilirubin to determine the molar ratio of bilirubin to albumin.
  • Measuring the change in difference spectra after excess free bilirubin addition to assess residual binding capacity.

    • Main Results:

    • Difference spectra changes are proportional to bound bilirubin up to a 1:1 molar ratio of bilirubin to albumin.
    • Increasing bilirubin beyond the 1:1 molar ratio does not alter the difference spectra.
    • The assay requires only 40 microliters of serum and is completed in under 10 minutes.

    Conclusions:

    • Difference spectroscopy provides a reliable method for assessing bilirubin-protein binding.
    • The developed assay can rapidly determine residual bilirubin binding capacity, aiding in kernicterus risk assessment.
    • This technique offers a clinically applicable tool for neonatal hyperbilirubinemia management.